NasdaqCM - Nasdaq Real Time Price USD

Biofrontera Inc. (BFRI)

0.6590
-0.0109
(-1.63%)
At close: May 20 at 4:00:01 PM EDT
0.6603
+0.00
+(0.20%)
Pre-Market: 8:00:05 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
37,997
37,321
34,071
28,674
24,100
Cost of Revenue
17,759
18,607
17,444
15,185
12,742
Gross Profit
20,238
18,714
16,627
13,489
11,358
Operating Expense
36,528
35,924
39,204
35,870
37,209
Operating Income
-16,290
-17,210
-22,577
-22,381
-25,851
Net Non Operating Interest Income Expense
-775
-2,076
-560
-203
-344
Other Income Expense
5,560
1,549
3,020
21,976
-11,462
Pretax Income
-11,505
-17,737
-20,117
-608
-37,657
Tax Provision
20
22
14
32
56
Net Income Common Stockholders
-11,525
-17,759
-20,131
-640
-37,713
Diluted NI Available to Com Stockholders
-11,525
-17,759
-20,131
-640
-37,713
Basic EPS
-0.81
--
-13.02
-0.48
-85.60
Diluted EPS
-0.81
--
-13.02
-0.48
-85.60
Basic Average Shares
6,828.9190
--
1,546.2970
1,334.9500
440.4110
Diluted Average Shares
6,828.9190
--
1,546.2970
1,334.9500
440.4110
Total Operating Income as Reported
-16,290
-17,210
-22,677
-18,581
-25,201
Total Expenses
54,287
54,531
56,648
51,055
49,951
Net Income from Continuing & Discontinued Operation
-11,525
-17,759
-20,131
-640
-37,713
Normalized Income
-16,138.6000
-18,983.5000
-22,519.1700
-17,946.5300
-28,842.7700
Interest Income
71
71
132
175
16
Interest Expense
805
2,106
600
370
360
Net Interest Income
-775
-2,076
-560
-203
-344
EBIT
-10,700
-15,631
-19,517
-238
-37,297
EBITDA
-9,639
-14,482
-18,453
934
-36,757
Reconciled Cost of Revenue
17,759
18,607
17,444
15,185
12,742
Reconciled Depreciation
1,061
1,149
1,064
1,172
540
Net Income from Continuing Operation Net Minority Interest
-11,525
-17,759
-20,131
-640
-37,713
Total Unusual Items Excluding Goodwill
5,840
1,550
3,023
21,907
-12,151
Total Unusual Items
5,840
1,550
3,023
21,907
-12,151
Normalized EBITDA
-15,479
-16,032
-21,476
-20,973
-24,606
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0003
Tax Effect of Unusual Items
1,226.4000
325.5000
634.8300
4,600.4700
-3,280.7700
12/31/2021 - 10/29/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PTPI Petros Pharmaceuticals, Inc.
0.1240
-6.13%
 
UPC Universe Pharmaceuticals INC
6.03
-4.13%
 
TLPH Talphera, Inc.
0.5155
+1.10%
 
SXTC China SXT Pharmaceuticals, Inc.
1.5600
-1.89%
 
DERM Journey Medical Corporation
6.88
+1.93%
 
APUS Apimeds Pharmaceuticals US, Inc
1.8500
+3.35%
 
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.2006
-3.19%
 
RDHL RedHill Biopharma Ltd.
1.9000
+0.53%
 
AKAN Akanda Corp.
1.2300
+1.65%
 
CVSI CV Sciences, Inc.
0.0300
+7.91%